BIOR - Biora Therapeutics, Inc. Stock Price, Fair Value and News

0.67USD+0.02 (+3.08%)Market Closed

Market Summary

USD0.67+0.02

Market Closed

3.08%

BIOR Stock Price

View Fullscreen

BIOR RSI Chart

BIOR Valuation

Market Cap

24.0M

Price/Earnings (Trailing)

-0.22

Price/Sales (Trailing)

84.71

EV/EBITDA

-0.32

Price/Free Cashflow

-0.49

BIOR Price/Sales (Trailing)

BIOR Profitability

EBT Margin

-36434.10%

Return on Equity

110.66%

Return on Assets

-482.22%

Free Cashflow Yield

-203.8%

BIOR Fundamentals

BIOR Revenue

Revenue (TTM)

305.0K

Rev. Growth (Yr)

6.7K%

Rev. Growth (Qtr)

49.72%

BIOR Earnings

Earnings (TTM)

-110.9M

Earnings Growth (Yr)

75.98%

Earnings Growth (Qtr)

72.82%

Breaking Down BIOR Revenue

Last 7 days

1.5%

Last 30 days

4.7%

Last 90 days

6.4%

Trailing 12 Months

-81.8%

How does BIOR drawdown profile look like?

BIOR Financial Health

Current Ratio

0.28

Debt/Equity

-0.19

Debt/Cashflow

-2.61

BIOR Investor Care

Shares Dilution (1Y)

202.59%

Diluted EPS (TTM)

-6.12

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	0	0	0	0
2023	0	0	0	0
2022	1.2M	828.0K	726.0K	305.0K
2021	414.0K	666.0K	918.0K	1.2M
2020	113.3M	73.3M	36.8M	162.0K
2019	132.0M	136.0M	140.0M	144.0M
2018	0	0	0	128.0M

Get all data in R, Python etc through our Historical Stock Data APIs

About Biora Therapeutics, Inc.

Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and Systemic oral delivery platform for oral delivery of large molecules for management of chronic diseases. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California.

CEO	Mr. Aditya P. Mohanty M.B.A.
WEBSITE	bioratherapeutics.com
INDUSTRY	Biotechnology
EMPLOYEES	54

Biora Therapeutics, Inc. Frequently Asked Questions

What is the ticker symbol for Biora Therapeutics, Inc.? What does BIOR stand for in stocks?

BIOR is the stock ticker symbol of Biora Therapeutics, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Biora Therapeutics, Inc. (BIOR)?

As of Fri Jul 26 2024, market cap of Biora Therapeutics, Inc. is 24.04 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of BIOR stock?

You can check BIOR's fair value in chart for subscribers.

Is Biora Therapeutics, Inc. a good stock to buy?

The fair value guage provides a quick view whether BIOR is over valued or under valued. Whether Biora Therapeutics, Inc. is cheap or expensive depends on the assumptions which impact Biora Therapeutics, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for BIOR.

What is Biora Therapeutics, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Jul 26 2024, BIOR's PE ratio (Price to Earnings) is -0.22 and Price to Sales (PS) ratio is 84.71. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. BIOR PE ratio will change depending on the future growth rate expectations of investors.